Celestica Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-83.3% vs price
Base Case (Median)
-71.7% vs price
Bull Case (75th pct.)
-44.7% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-18.05 | -105.7% | High (40%) |
| PE Comparable | $244.83 | -23.1% | Medium (25%) |
| Growth Trajectory DCF | $536.74 | 68.7% | Medium (20%) |
| Graham Number | $64.48 | -79.7% | Low (10%) |
| EV/EBITDA | $106.91 | -66.4% | Medium (20%) |
| EV/FCF | $90.19 | -71.7% | Medium (20%) |
| Earnings Power Value | $41.86 | -86.8% | Medium (50%) |
Based on 7 out of 8 methods, CLS appears overvalued at the current price of $318.24. The base case fair value of $90.19 implies 71.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.